Event | Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder | November 14, 2024
Dear Colleagues,
Please see the next Medical Genetics Grand Rounds scheduled talk below:
Philippe Gros appointed Chief Scientific Officer of D2R
Philippe Gros appointed Chief Scientific Officer of D2RPhilippe Gros has been appointed Chief Scientific Officer (CSO) of 涩里番鈥檚 DNA to RNA (D2R) Initiative, effective September 30, 2024. Prior to this role, he served as Deputy Vice-President (Research and Innovation) at 涩里番. This appointment follows a thorough international search, with the selection committee enthusiastic about their recommendation.
D2R welcomes RNA and genomic researchers to Universit茅 de Sherbrooke
D2R welcomes RNA and genomic researchers to Universit茅 de SherbrookeMontreal 鈥� October 31, 2024 鈥� 涩里番鈥檚 DNA to RNA (D2R) research initiative is proud to announce the appointment of three new researchers at Universit茅 de Sherbrooke, marking the inaugural recipients of the D2R鈥檚 New Faculty Start-Up funding program. Universit茅 de Sherbrooke is a partner institution in the D2R initiative, working collaboratively to advance genomic and RNA research.
Event | Practical research experience in a First Nations environment in the field of health and social services evaluation | Dec 20, 2024
Practical research experience in First Nations communities in the field of health and social services evaluationDecember 20, 2024 | 12 h 脿 13 h Speaker: Cecilia Valdebenito, anthropologist
This webinar has two objectives:
News | 2024 Nobel Prize awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation
The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.This year鈥檚 Nobel Prize focuses on the discovery of a vital regulatory mechanism used in cells to control gene activity. Genetic information flows from DNA to messenger RNA (mRNA), via a process called transcription, and then on to the cellular machinery for protein production.
Event | Controlling RNA Sequence for Diagnostics and Therapeutic Delivery | January 5-10, 2025
RNA Nanotechnology - Gordon Research Conference (GRC) Controlling RNA Sequence for Diagnostics and Therapeutic DeliveryJanuary 5 - 10, 2025
Ventura, California, United States
Congratulations to Dr. Raquel Cuella Martin on receiving Gairdner Foundation Early Career Investigator Award
Congratulations to Dr. Raquel Cuella Martin on receiving the prestigious Gairdner Foundation Early Career Investigator Award. As an Assistant Professor of Human Genetics at 涩里番, Dr. Cuella Martin is pushing the boundaries of science with her lab, which uses precision genome editing to tackle complex biological problems.
News | G茅nome Qu茅bec invests up to $500,000 to boost RNA therapeutics innovation in Quebec
G茅nome Qu茅bec invests up to $500,000 to boost RNA therapeutics innovation in QuebecG茅nome Qu茅bec, a private, non-profit organization dedicated to advancing genomics research and innovation in Quebec, is investing up to $500,000 in 涩里番鈥檚 D2R Initiative. This investment will advance the commercialization of innovative genomic technologies in Quebec through D2R鈥檚 Commercialization Priming funding program.
Event | Genes, genealogy, and geography: A genetic history of Quebec | Oct 3, 2024
Join 涩里番 Health Centre's next 鈥淢edical Genetics Grand Rounds鈥�The founder effect, which is observed in certain regions of Quebec, can increase susceptibility to rare disease. This stems from the fact that these communities were founded by populations that were already related.
Event | Indigenous Perspectives on Truth and Reconciliation in Post-Secondary Education | Sept 30, 2024
In honour of National Day for Truth and Reconciliation, 涩里番's School of Continuing Studies is organizing an online panel discussion on Truth and Reconciliation within the post-secondary education system.
About the event:聽Title:聽Indigenous Perspectives on Truth and Reconciliation in Post-Secondary Education
Date & Time: Monday September 30, 2024 from 12-1pm
Format: On Zoom
News | D2R awards $7.3 million to Advance Research in Genomic-Based RNA Therapeutics
D2R awards $7.3 million to Advance Research in Genomic-Based RNA TherapeuticsMontreal 鈥� September 17, 2024聽 涩里番鈥檚 D2R initiative is proud to announce the 23 recipients of its inaugural funding programs, Foundational Projects and Research in Motion. With a total investment of $7.3 million, these awards mark a significant milestone in advancing the field of genomic-based RNA therapeutics.
News | Pleins feux sur la technologie ARN | La Presse
A recent article in La Presse, Pleins feux sur la technologie ARN, highlights how Quebec's life sciences sector is experiencing a significant revival with the creation of an RNA hub.
Here is a exerpt from the article (translated to english):聽
D2R Funding Opportunity | Core Platform Sustainability & Centres and Institutes Support
D2R | DNA to RNA, the research initiative at 涩里番 that is taking an inclusive Canadian approach to genomic-based RNA therapeutics is offering two new funding opportunities:
Event | Diversity, Equity, & Inclusion Workshop | Sept 23 at 10:30am
In this collaborative session you will learn about the value of Diversity Equity & Inclusion in the Institute of Genomic Medicine, how to access relevant resources through 涩里番 services, and discuss real case studies to explore the ways 涩里番 services and best practices can be applied to your workplace.
Event details:Title: Diversity, Equity, & Inclusion Workshop
Podcast | The Canadian Breakpoint with special guest Dr. Thomas Duchaine
In a recent episode of聽The Canadian Breakpoint podcast,聽Dr. Rupeena Purewal sits down with Dr. Thomas Duchaine, Director of 涩里番's Centre for RNA Sciences, to talk about the transformative potential of mRNA medicines. The episode explores how mRNA is emerging as a versatile therapeutic modality, with potential from vaccines to personalized medicine.
